EfficientIn VivoGene Transfer into the Heart in the Rat Myocardial Infarction Model Using the HVJ (Hemagglutinating Virus of Japan)—Liposome Method

Motokuni Aoki(Osaka City University), Toshio Ogihara(Osaka University), Toshiko Sugimoto(Mochida Pharmaceutical (Japan)), Victor J. Dzau(Duke Medical Center), Yasufumi Kaneda(Osaka University), Kazuhiro Maeda(Jikei University School of Medicine), Atsushi Moriguchi(The University of Osaka), Ryuichi Morishita(The University of Osaka), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Akihiko Muraishi(Kurume University)
Journal of Molecular and Cellular Cardiology
March 1, 1997
10.1006/jmcc.1996.0337
Cited by 54

Related Papers

Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
MicroRNA-Mediated In Vitro and In Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes
|Circulation Research|2012|767
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588